A single dose of psychedelic drug eased cancer patients' anxiety and depression for years

  • 📰 NBCNews
  • ⏱ Reading Time:
  • 8 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 86%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Nearly five years after a group of cancer patients were given a single dose of a psychedelic drug to ease depression and anxiety, new research finds that many of them are still feeling the positive effects.

Anxiety and depression among cancer patients and survivors is “very common and very consequential,” Ross said. Up to 40 percent of cancer patients develop cancer-related anxiety and depression, according to the study. And the effects that depression and anxiety have on both mental and physical health can be fatal.

“It’s a powerful experience that creates a lasting memory that involves them dealing with the demons of their cancer or their mortality,” Ross said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Just another new addiction!!

I need a batch for my friends

Dark_Toss But they're just fungis!

Illenesses fight against human over the world. All kind of cancer has as origine a bad nutrition and drug abuse. Now human is very weak. He deads soon after his oldness. I see medecine has to drive some new researchs to fill the gap of this weakness. More of solutions can be seen

legalized commercialized pharma ... V ... illegal free nature? .

A possible cure for anxiety is magic mushrooms? Sign me up! 45 years of anxiety is enough, I would like a day off please

gol_mia Conservatives don't care, Drugs bad so let people suffer

Shophiea1 Infected Mushroom 🍄👌🎃

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 10. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Taking on the Lack of Diversity in Cancer TrialsIn 2018, less than 450 people of color were included in clinical trials for drug approvals, which is a problem, because drugs may not affect everyone the same. WebMD Chief Medical Officer drjohnwhyte discusses what the FDA and SU2C are doing to help:
Source: WebMD - 🏆 709. / 51 Read more »